Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry StudyTessa Straatmijer, Joep Grootjans, Nynke Boontje et al.|Clinical Gastroenterology and Hepatology|2022Cited by 51
Identification of a Disease-Associated Network of Intestinal Immune Cells in Treatment-Naive Inflammatory Bowel DiseaseVincent van Unen, Frits Koning, Laura F. Ouboter et al.|Frontiers in Immunology|2022Cited by 34
Prophylactic Medication for the Prevention of Endoscopic Recurrence in Crohn’s Disease: a Prospective Study Based on Clinical Risk StratificationJeanine Arkenbosch, Annemarie C. de Vries, Evelien Beelen et al.|Journal of Crohn s and Colitis|2022Cited by 31
Combined Clinical and Histopathological Risk Stratification for Prediction of (severe) Endoscopic Postoperative Recurrence in Patients with Crohn’s Disease after Ileocolic ResectionMichiel T. Bak, Lindsey Oudijk, Ariadne H.A.G. Ooms et al.|Annals of Surgery|2025Cited by 5
P284 Prophylactic medication for the prevention of endoscopic recurrence after ileocolonic resection in Crohn’s disease: a prospective study based on clinical risk stratificationJeanine Arkenbosch, Annemarie C. de Vries, Evelien Beelen et al.|Journal of Crohn s and Colitis|2022Cited by 3